Benin

Benin

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.56 (6.20 - 8.82) 2019 Modelled IHME
7.88 (6.59 - 9.04) 2018 Modelled IHME
8.17 (6.63 - 9.42) 2017 Modelled IHME
8.4 (6.73 - 9.72) 2016 Modelled IHME
8.63 (6.79 - 10.20) 2015 Modelled IHME
8.89 (6.99 - 10.42) 2014 Modelled IHME
9.17 (7.28 - 10.67) 2013 Modelled IHME
9.48 (7.60 - 10.92) 2012 Modelled IHME
9.79 (7.94 - 11.29) 2011 Modelled IHME
10.12 (8.20 - 11.69) 2010 Modelled IHME
10.48 (8.51 - 12.07) 2009 Modelled IHME
10.87 (8.75 - 12.57) 2008 Modelled IHME
11.28 (8.97 - 13.15) 2007 Modelled IHME
11.68 (9.19 - 13.76) 2006 Modelled IHME
12.05 (9.39 - 14.34) 2005 Modelled IHME
12.42 (9.61 - 14.76) 2004 Modelled IHME
12.82 (9.84 - 15.28) 2003 Modelled IHME
13.19 (10.05 - 15.76) 2002 Modelled IHME
13.48 (10.20 - 16.14) 2001 Modelled IHME
13.67 (10.27 - 16.40) 2000 Modelled IHME
13.77 (10.40 - 16.37) 1999 Modelled IHME
13.87 (10.49 - 16.45) 1998 Modelled IHME
13.94 (10.57 - 16.54) 1997 Modelled IHME
14 (10.64 - 16.67) 1996 Modelled IHME
14.02 (10.70 - 16.74) 1995 Modelled IHME
14.02 (10.81 - 16.63) 1994 Modelled IHME
14.02 (10.87 - 16.54) 1993 Modelled IHME
14.01 (10.90 - 16.47) 1992 Modelled IHME
13.98 (10.99 - 16.48) 1991 Modelled IHME
13.94 (11.02 - 16.53) 1990 Modelled IHME
10.95 (8.15 - 14.20) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.79 (1.84 - 3.63) 2019 Modelled IHME
3.16 (2.20 - 3.99) 2018 Modelled IHME
3.33 (2.35 - 4.32) 2017 Modelled IHME
3.33 (2.28 - 4.24) 2016 Modelled IHME
3.3 (2.15 - 4.26) 2015 Modelled IHME
3.17 (2.01 - 4.04) 2014 Modelled IHME
2.87 (1.83 - 3.64) 2013 Modelled IHME
2.53 (1.66 - 3.19) 2012 Modelled IHME
2.25 (1.55 - 2.83) 2011 Modelled IHME
2.13 (1.50 - 2.71) 2010 Modelled IHME
2.25 (1.60 - 2.87) 2009 Modelled IHME
2.6 (1.81 - 3.34) 2008 Modelled IHME
3.11 (2.12 - 4.02) 2007 Modelled IHME
3.74 (2.51 - 4.87) 2006 Modelled IHME
4.42 (2.91 - 5.81) 2005 Modelled IHME
5.62 (3.64 - 7.30) 2004 Modelled IHME
7.47 (4.79 - 9.61) 2003 Modelled IHME
9.47 (6.05 - 12.07) 2002 Modelled IHME
11.12 (7.14 - 14.27) 2001 Modelled IHME
11.92 (7.71 - 15.55) 2000 Modelled IHME
12.12 (7.87 - 15.69) 1999 Modelled IHME
12.28 (8.05 - 15.87) 1998 Modelled IHME
12.4 (8.19 - 16.13) 1997 Modelled IHME
12.47 (8.27 - 16.36) 1996 Modelled IHME
12.5 (8.29 - 16.38) 1995 Modelled IHME
12.49 (8.32 - 16.22) 1994 Modelled IHME
12.46 (8.28 - 16.03) 1993 Modelled IHME
12.4 (8.25 - 15.98) 1992 Modelled IHME
12.32 (8.26 - 15.78) 1991 Modelled IHME
12.19 (8.16 - 15.48) 1990 Modelled IHME
5.55 (3.62 - 8.14) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
676,239 (534,564 - 801,941) 1990 Modelled IHME
701,693 (551,599 - 827,057) 1991 Modelled IHME
726,929 (565,990 - 854,798) 1992 Modelled IHME
751,985 (582,847 - 886,991) 1993 Modelled IHME
776,974 (598,810 - 921,465) 1994 Modelled IHME
802,099 (612,413 - 957,775) 1995 Modelled IHME
826,657 (628,593 - 984,622) 1996 Modelled IHME
850,012 (644,601 - 1,008,460) 1997 Modelled IHME
872,543 (660,306 - 1,035,370) 1998 Modelled IHME
894,625 (675,436 - 1,063,680) 1999 Modelled IHME
916,670 (689,138 - 1,100,010) 2000 Modelled IHME
934,171 (706,449 - 1,118,470) 2001 Modelled IHME
943,908 (719,356 - 1,128,180) 2002 Modelled IHME
948,413 (727,949 - 1,130,500) 2003 Modelled IHME
950,488 (734,883 - 1,129,100) 2004 Modelled IHME
953,387 (742,772 - 1,134,440) 2005 Modelled IHME
955,899 (752,032 - 1,126,330) 2006 Modelled IHME
955,280 (759,559 - 1,114,050) 2007 Modelled IHME
953,016 (766,741 - 1,102,180) 2008 Modelled IHME
950,810 (772,298 - 1,094,650) 2009 Modelled IHME
950,535 (770,084 - 1,097,160) 2010 Modelled IHME
951,738 (771,360 - 1,097,480) 2011 Modelled IHME
952,823 (764,449 - 1,098,350) 2012 Modelled IHME
954,194 (756,905 - 1,109,450) 2013 Modelled IHME
956,309 (752,315 - 1,120,560) 2014 Modelled IHME
959,700 (754,952 - 1,134,470) 2015 Modelled IHME
965,494 (773,924 - 1,117,060) 2016 Modelled IHME
969,750 (787,717 - 1,119,290) 2017 Modelled IHME
966,919 (808,062 - 1,108,740) 2018 Modelled IHME
957,571 (785,889 - 1,116,630) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
8.05 (5.65 - 10.90) 2019 Modelled IHME
8.2 (5.75 - 11) 2018 Modelled IHME
8.52 (6.05 - 11.30) 2017 Modelled IHME
8.64 (6.24 - 11.50) 2016 Modelled IHME
8.93 (6.48 - 11.70) 2015 Modelled IHME
9.39 (6.82 - 12.30) 2014 Modelled IHME
9.91 (7.27 - 13) 2013 Modelled IHME
10.5 (7.69 - 13.60) 2012 Modelled IHME
10.9 (8.07 - 14.20) 2011 Modelled IHME
11.2 (8.26 - 14.60) 2010 Modelled IHME
11.4 (8.34 - 14.50) 2009 Modelled IHME
11.4 (8.31 - 14.70) 2008 Modelled IHME
11.6 (8.47 - 15) 2007 Modelled IHME
11.9 (8.73 - 15.50) 2006 Modelled IHME
12.3 (9.04 - 16) 2005 Modelled IHME
12.7 (9.34 - 16.60) 2004 Modelled IHME
13.1 (9.59 - 17.30) 2003 Modelled IHME
13.6 (9.94 - 18.20) 2002 Modelled IHME
14 (10.10 - 19) 2001 Modelled IHME
14.2 (10.30 - 19) 2000 Modelled IHME
14.3 (10.30 - 19.10) 1999 Modelled IHME
14.5 (10.60 - 19.40) 1998 Modelled IHME
14.7 (10.70 - 19.70) 1997 Modelled IHME
14.8 (10.80 - 19.70) 1996 Modelled IHME
14.9 (10.80 - 19.70) 1995 Modelled IHME
14.9 (10.70 - 19.70) 1994 Modelled IHME
14.9 (10.80 - 19.80) 1993 Modelled IHME
15 (10.90 - 19.90) 1992 Modelled IHME
15.1 (11 - 20) 1991 Modelled IHME
15.2 (11.10 - 20.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,020 (715 - 1,377) 2019 Modelled IHME
1,006 (706 - 1,355) 2018 Modelled IHME
1,012 (719 - 1,340) 2017 Modelled IHME
994 (717 - 1,320) 2016 Modelled IHME
994 (720 - 1,303) 2015 Modelled IHME
1,011 (734 - 1,320) 2014 Modelled IHME
1,031 (756 - 1,351) 2013 Modelled IHME
1,051 (774 - 1,369) 2012 Modelled IHME
1,064 (784 - 1,377) 2011 Modelled IHME
1,055 (775 - 1,369) 2010 Modelled IHME
1,030 (757 - 1,320) 2009 Modelled IHME
1,001 (729 - 1,289) 2008 Modelled IHME
982 (718 - 1,268) 2007 Modelled IHME
975 (715 - 1,265) 2006 Modelled IHME
969 (716 - 1,266) 2005 Modelled IHME
970 (714 - 1,271) 2004 Modelled IHME
971 (709 - 1,278) 2003 Modelled IHME
976 (712 - 1,302) 2002 Modelled IHME
969 (702 - 1,314) 2001 Modelled IHME
953 (689 - 1,277) 2000 Modelled IHME
926 (669 - 1,241) 1999 Modelled IHME
914 (667 - 1,223) 1998 Modelled IHME
895 (653 - 1,200) 1997 Modelled IHME
877 (638 - 1,165) 1996 Modelled IHME
852 (617 - 1,125) 1995 Modelled IHME
826 (594 - 1,091) 1994 Modelled IHME
798 (577 - 1,062) 1993 Modelled IHME
777 (564 - 1,033) 1992 Modelled IHME
758 (551 - 1,006) 1991 Modelled IHME
737 (541 - 979) 1990 Modelled IHME
1,683 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
47 (39 - 55) 2019 Modelled IHME
47 (39 - 55) 2018 Modelled IHME
47 (39 - 55) 2017 Modelled IHME
47 (39 - 56) 2016 Modelled IHME
47 (39 - 56) 2015 Modelled IHME
47 (39 - 56) 2014 Modelled IHME
48 (40 - 56) 2013 Modelled IHME
48 (40 - 57) 2012 Modelled IHME
49 (41 - 57) 2011 Modelled IHME
49 (41 - 57) 2010 Modelled IHME
49 (40 - 57) 2009 Modelled IHME
49 (41 - 57) 2008 Modelled IHME
49 (41 - 58) 2007 Modelled IHME
49 (40 - 57) 2006 Modelled IHME
49 (40 - 57) 2005 Modelled IHME
49 (41 - 58) 2004 Modelled IHME
49 (41 - 58) 2003 Modelled IHME
50 (41 - 58) 2002 Modelled IHME
50 (41 - 58) 2001 Modelled IHME
50 (41 - 58) 2000 Modelled IHME
50 (42 - 59) 1999 Modelled IHME
50 (42 - 59) 1998 Modelled IHME
50 (42 - 59) 1997 Modelled IHME
50 (42 - 59) 1996 Modelled IHME
50 (42 - 59) 1995 Modelled IHME
50 (42 - 59) 1994 Modelled IHME
50 (42 - 59) 1993 Modelled IHME
50 (41 - 59) 1992 Modelled IHME
50 (41 - 59) 1991 Modelled IHME
50 (41 - 59) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
76 2018 Survey/reported WHO/UNICEF
76 2017 Survey/reported WHO/UNICEF
76 2016 Survey/reported WHO/UNICEF
74 2015 Survey/reported WHO/UNICEF
74 2014 Survey/reported WHO/UNICEF
77 2013 Survey/reported WHO/UNICEF
80 2012 Survey/reported WHO/UNICEF
75 2011 Survey/reported WHO/UNICEF
76 2010 Survey/reported WHO/UNICEF
79 2009 Survey/reported WHO/UNICEF
75 2008 Survey/reported WHO/UNICEF
82 2007 Survey/reported WHO/UNICEF
74 2006 Survey/reported WHO/UNICEF
70 2005 Survey/reported WHO/UNICEF
75 2004 Survey/reported WHO/UNICEF
73 2003 Survey/reported WHO/UNICEF
15 2002 Survey/reported WHO/UNICEF
76 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
3.09 (2.45 - 3.91) 2019 Modelled IHME
3.16 (2.53 - 3.97) 2018 Modelled IHME
3.22 (2.57 - 4.04) 2017 Modelled IHME
3.28 (2.65 - 4.07) 2016 Modelled IHME
3.34 (2.67 - 4.14) 2015 Modelled IHME
3.38 (2.71 - 4.19) 2014 Modelled IHME
3.42 (2.74 - 4.23) 2013 Modelled IHME
3.45 (2.76 - 4.26) 2012 Modelled IHME
3.47 (2.77 - 4.28) 2011 Modelled IHME
3.48 (2.76 - 4.31) 2010 Modelled IHME
3.48 (2.79 - 4.31) 2009 Modelled IHME
3.46 (2.79 - 4.32) 2008 Modelled IHME
3.45 (2.77 - 4.32) 2007 Modelled IHME
3.44 (2.76 - 4.33) 2006 Modelled IHME
3.43 (2.76 - 4.34) 2005 Modelled IHME
3.45 (2.77 - 4.38) 2004 Modelled IHME
3.48 (2.81 - 4.42) 2003 Modelled IHME
3.52 (2.84 - 4.45) 2002 Modelled IHME
3.56 (2.87 - 4.47) 2001 Modelled IHME
3.59 (2.87 - 4.50) 2000 Modelled IHME
3.6 (2.89 - 4.51) 1999 Modelled IHME
3.62 (2.90 - 4.54) 1998 Modelled IHME
3.64 (2.91 - 4.58) 1997 Modelled IHME
3.65 (2.91 - 4.57) 1996 Modelled IHME
3.67 (2.92 - 4.59) 1995 Modelled IHME
3.7 (2.95 - 4.63) 1994 Modelled IHME
3.72 (2.97 - 4.67) 1993 Modelled IHME
3.75 (3 - 4.73) 1992 Modelled IHME
3.78 (3.02 - 4.80) 1991 Modelled IHME
3.82 (3.05 - 4.87) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.6 (3.60 - 12.80) 2014 Modelled Gower et al, 2014
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
185,310 (147,941 - 236,553) 1990 Modelled IHME
189,960 (151,716 - 241,150) 1991 Modelled IHME
194,737 (155,540 - 245,441) 1992 Modelled IHME
199,659 (159,540 - 250,295) 1993 Modelled IHME
204,763 (163,432 - 256,302) 1994 Modelled IHME
210,108 (167,102 - 262,508) 1995 Modelled IHME
215,760 (172,063 - 270,110) 1996 Modelled IHME
221,703 (177,348 - 279,040) 1997 Modelled IHME
227,867 (182,418 - 285,925) 1998 Modelled IHME
234,159 (187,924 - 292,960) 1999 Modelled IHME
240,467 (192,652 - 302,122) 2000 Modelled IHME
246,316 (198,723 - 309,503) 2001 Modelled IHME
251,710 (203,576 - 318,235) 2002 Modelled IHME
257,273 (207,751 - 326,988) 2003 Modelled IHME
263,689 (211,792 - 335,261) 2004 Modelled IHME
271,740 (218,387 - 343,485) 2005 Modelled IHME
281,494 (226,319 - 354,712) 2006 Modelled IHME
292,235 (234,878 - 365,815) 2007 Modelled IHME
303,632 (244,543 - 378,244) 2008 Modelled IHME
315,296 (252,829 - 391,014) 2009 Modelled IHME
326,750 (259,351 - 404,687) 2010 Modelled IHME
337,298 (268,868 - 415,964) 2011 Modelled IHME
346,741 (277,305 - 428,218) 2012 Modelled IHME
355,332 (285,028 - 439,897) 2013 Modelled IHME
363,372 (291,898 - 451,092) 2014 Modelled IHME
371,211 (297,431 - 460,843) 2015 Modelled IHME
377,441 (304,178 - 468,143) 2016 Modelled IHME
382,268 (304,642 - 479,790) 2017 Modelled IHME
387,123 (310,150 - 486,647) 2018 Modelled IHME
391,540 (310,916 - 495,023) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.37 (0.94 - 1.92) 2019 Modelled IHME
1.38 (0.95 - 1.95) 2018 Modelled IHME
1.41 (0.98 - 1.97) 2017 Modelled IHME
1.39 (0.96 - 1.94) 2016 Modelled IHME
1.39 (0.97 - 1.96) 2015 Modelled IHME
1.41 (0.98 - 2) 2014 Modelled IHME
1.42 (1 - 2.03) 2013 Modelled IHME
1.44 (1 - 2.05) 2012 Modelled IHME
1.46 (1.01 - 2.09) 2011 Modelled IHME
1.47 (1.01 - 2.09) 2010 Modelled IHME
1.48 (1.03 - 2.10) 2009 Modelled IHME
1.48 (1.02 - 2.10) 2008 Modelled IHME
1.49 (1.03 - 2.10) 2007 Modelled IHME
1.53 (1.07 - 2.11) 2006 Modelled IHME
1.56 (1.10 - 2.12) 2005 Modelled IHME
1.6 (1.12 - 2.18) 2004 Modelled IHME
1.63 (1.15 - 2.19) 2003 Modelled IHME
1.67 (1.19 - 2.22) 2002 Modelled IHME
1.7 (1.22 - 2.25) 2001 Modelled IHME
1.73 (1.25 - 2.29) 2000 Modelled IHME
1.75 (1.27 - 2.31) 1999 Modelled IHME
1.78 (1.29 - 2.37) 1998 Modelled IHME
1.8 (1.31 - 2.39) 1997 Modelled IHME
1.82 (1.33 - 2.43) 1996 Modelled IHME
1.83 (1.33 - 2.44) 1995 Modelled IHME
1.84 (1.34 - 2.46) 1994 Modelled IHME
1.85 (1.35 - 2.46) 1993 Modelled IHME
1.87 (1.35 - 2.50) 1992 Modelled IHME
1.9 (1.38 - 2.53) 1991 Modelled IHME
1.93 (1.39 - 2.56) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
174 (119 - 243) 2019 Modelled IHME
170 (117 - 239) 2018 Modelled IHME
168 (116 - 234) 2017 Modelled IHME
160 (111 - 223) 2016 Modelled IHME
155 (108 - 218) 2015 Modelled IHME
152 (106 - 215) 2014 Modelled IHME
148 (104 - 211) 2013 Modelled IHME
145 (100 - 206) 2012 Modelled IHME
142 (98 - 203) 2011 Modelled IHME
138 (94 - 196) 2010 Modelled IHME
134 (93 - 190) 2009 Modelled IHME
130 (89 - 184) 2008 Modelled IHME
127 (88 - 178) 2007 Modelled IHME
125 (88 - 173) 2006 Modelled IHME
123 (87 - 168) 2005 Modelled IHME
122 (86 - 166) 2004 Modelled IHME
121 (85 - 162) 2003 Modelled IHME
119 (85 - 159) 2002 Modelled IHME
118 (84 - 156) 2001 Modelled IHME
116 (84 - 153) 2000 Modelled IHME
114 (82 - 150) 1999 Modelled IHME
112 (81 - 149) 1998 Modelled IHME
110 (80 - 146) 1997 Modelled IHME
108 (79 - 143) 1996 Modelled IHME
105 (76 - 140) 1995 Modelled IHME
102 (74 - 136) 1994 Modelled IHME
99 (72 - 132) 1993 Modelled IHME
97 (70 - 130) 1992 Modelled IHME
95 (69 - 127) 1991 Modelled IHME
93 (67 - 124) 1990 Modelled IHME
370 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
17 (12 - 24) 2019 Modelled IHME
17 (12 - 24) 2018 Modelled IHME
17 (12 - 24) 2017 Modelled IHME
17 (12 - 24) 2016 Modelled IHME
18 (12 - 24) 2015 Modelled IHME
17 (12 - 24) 2014 Modelled IHME
17 (12 - 23) 2013 Modelled IHME
17 (12 - 23) 2012 Modelled IHME
17 (12 - 23) 2011 Modelled IHME
17 (12 - 23) 2010 Modelled IHME
17 (12 - 23) 2009 Modelled IHME
17 (12 - 23) 2008 Modelled IHME
17 (12 - 23) 2007 Modelled IHME
17 (12 - 24) 2006 Modelled IHME
17 (12 - 23) 2005 Modelled IHME
17 (12 - 23) 2004 Modelled IHME
17 (12 - 23) 2003 Modelled IHME
17 (12 - 23) 2002 Modelled IHME
17 (12 - 23) 2001 Modelled IHME
17 (11 - 23) 2000 Modelled IHME
17 (11 - 23) 1999 Modelled IHME
17 (11 - 23) 1998 Modelled IHME
17 (11 - 23) 1997 Modelled IHME
17 (11 - 23) 1996 Modelled IHME
17 (11 - 23) 1995 Modelled IHME
17 (12 - 23) 1994 Modelled IHME
17 (12 - 24) 1993 Modelled IHME
18 (12 - 24) 1992 Modelled IHME
18 (12 - 24) 1991 Modelled IHME
18 (12 - 24) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
1,020
2019
(715 - 1,377)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
174
2019
(119 - 243)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines